Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Gastroenterology

Development and validation of a nomogram for predicting 28-day mortality in critically ill liver cirrhotic patients with coagulopathy

  1. 1Endoscopy Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005 China
  2. 2Endoscopy Center, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212 China
  3. 3Department of Anesthesiology, Fujian Medical University Union Hospital, Fuzhou, 350001 China

Abstract

Background: Although scoring systems exist to predict outcomes in patients with cirrhosis, specific systems for critically ill cirrhotic patients with coagulopathy are lacking. The aim of the study was to establish a reliable predictive model for 28-day mortality in cirrhotic patients with coagulopathy admitted to the intensive care unit.

Methods: The 880 cirrhotic patients with coagulopathy admitted to the intensive care unit from 2008 to 2022 in the Medical Information Mart for Intensive Care-IV database were randomly allocated to training (n = 616) and validation (n = 264) cohorts. Independent predictors of 28-day mortality were identified by logistic regression analysis and used to construct a nomogram.

Results: Age, white blood cell count, activated partial thromboplastin time, prothrombin time, total bilirubin level, blood lactate level, and blood bicarbonate level were identified as independent predictors of 28-day mortality. The nomogram showed good discrimination in the training (concordance index, 0.885; 95% confidence interval, 0.855–0.915) and validation (concordance index, 0.909; 95% confidence interval, 0.871–0.948) cohorts. Calibration, receiver operating characteristic, and clinical decision curves showed that the nomogram had good predictive ability.

Conclusions: The nomogram exhibited superior discernment and accuracy to SOFA, MELD3.0, ABIC scores and may help identify high-risk patients to allow early intervention and potentially improve clinical outcomes.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12876-026-05367-3.

Related

  1. Development and validation of an interpretable machine learning model for predicting in-hospital mortality among critically ill patients with liver cirrhosis
    Fengjie Guo, Shijie Zhong, Yang Tan +6
    Scientific ReportsPeer-reviewedCC BYFull text1 citedGeneral medicineDOAJ
  2. Development and validation of a novel metabolic-inflammatory health-related nomogram for predicting in-hospital mortality in older patients with type 2 diabetes mellitus combined with cardiovascular disease
    Juntao Tan, Tailin Dong, Yuxin He +1
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Feature-token clinical transformer for 24-h landmark mortality risk stratification in critically ill patients with heart failure: development and multicenter external validation
    Mianxian Li, Yuefei Zhou, Chun Li
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefEurope PMCEurope PMCPMC
  4. An interpretable machine learning model for predicting intensive care unit mortality risk in elderly patients with concomitant cardiogenic shock and sepsis: Development and external validation using two large critical care databases
    Han Chen, Yuming Wu, Pu Chen +3
    Digital HealthPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  5. Development and external validation of machine learning models for predicting mortality in patients with lung cancer: a multicenter retrospective cohort study
    Lihui Liu, Pan Zuo, Chunlan Yu +7
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
BibTeX
@article{lin2026development,
  title = {{Development and validation of a nomogram for predicting 28-day mortality in critically ill liver cirrhotic patients with coagulopathy}},
  author = {Yongxu Lin and Liqin Wei and Xujin Wei and Yuping Wang and Jiaxin Shen and Wenming Liu},
  journal = {BMC Gastroenterology},
  year = {2026},
  month = sep,
  doi = {10.1186/s12876-026-05367-3},
  url = {https://doi.org/10.1186/s12876-026-05367-3},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Development and validation of a nomogram for predicting 28-day mortality in critically ill liver cirrhotic patients with coagulopathy
AU  - Yongxu Lin
AU  - Liqin Wei
AU  - Xujin Wei
AU  - Yuping Wang
AU  - Jiaxin Shen
AU  - Wenming Liu
PY  - 2026
DA  - 2026/09/01
JO  - BMC Gastroenterology
DO  - 10.1186/s12876-026-05367-3
UR  - https://doi.org/10.1186/s12876-026-05367-3
AB  - Background: Although scoring systems exist to predict outcomes in patients with cirrhosis, specific systems for critically ill cirrhotic patients with coagulopathy are lacking. The aim of the study was to establish a reliable predictive model for 28-day mortality in cirrhotic patients with coagulopathy admitted to the intensive care unit.  Methods: The 880 cirrhotic patients with coagulopathy admitted to the intensive care unit from 2008 to 2022 in the Medical Information Mart for Intensive Care-IV database were randomly allocated to training (n = 616) and validation (n = 264) cohorts. Independent predictors of 28-day mortality were identified by logistic regression analysis and used to construct a nomogram.  Results: Age, white blood cell count, activated partial thromboplastin time, prothrombin time, total bilirubin level, blood lactate level, and blood bicarbonate level were identified as independent predictors of 28-day mortality. The nomogram showed good discrimination in the training (concordance index, 0.885; 95% confidence interval, 0.855–0.915) and validation (concordance index, 0.909; 95% confidence interval, 0.871–0.948) cohorts. Calibration, receiver operating characteristic, and clinical decision curves showed that the nomogram had good predictive ability.  Conclusions: The nomogram exhibited superior discernment and accuracy to SOFA, MELD3.0, ABIC scores and may help identify high-risk patients to allow early intervention and potentially improve clinical outcomes.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12876-026-05367-3.
SN  - 1471-230X
ER  -